Cargando…

Expression of CMV protein pp65 in cutaneous malignant melanoma

Human cytomegalovirus (CVM) has been detected by immunohistochemistry (IHC) in brain tumours; however, whether CMV antigen is seen in melanomas has not yet been elucidated. Applying IHC, melanoma tissue was assessed for the expression of pp65, a tegument protein of CMV. Two cohorts were available, c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agnarsdóttir, Margrét, Popova, Svetlana, Alafuzoff, Irina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788690/ https://www.ncbi.nlm.nih.gov/pubmed/31603931 http://dx.doi.org/10.1371/journal.pone.0223854

Ejemplares similares

Is CMV a target in pediatric glioblastoma? Expression of CMV proteins, pp65 and IE1-72 and CMV nucleic acids in a cohort of pediatric glioblastoma patients
por: Wakefield, Amanda, et al.
Publicado: (2015)

CMV pp65 and IE-1 T cell epitopes recognized by healthy subjects
por: Slezak, Stefanie L, et al.
Publicado: (2007)

Transactive DNA Binding Protein 43 Rather Than Other Misfolded Proteins in the Brain is Associated with Islet Amyloid Polypeptide in Pancreas in Aged Subjects with Diabetes Mellitus
por: Leino, Marina, et al.
Publicado: (2017)

Human Cytomegalovirus Tegument Protein pp65 Is Detected in All Intra- and Extra-Axial Brain Tumours Independent of the Tumour Type or Grade
por: Libard, Sylwia, et al.
Publicado: (2014)

The impact of standardized care pathway on reporting time for invasive melanoma – results from one pathology department in Sweden
por: Agnarsdóttir, Margrét, et al.
Publicado: (2019)

Altered Proteins in the Aging Brain
por: Elobeid, Adila, et al.
Publicado: (2016)

Cutaneous malignant melanoma in Scotland.
por: MacKie, R. M., et al.
Publicado: (1982)

Prognostic Value of Melanoma Inhibitory Activity Protein in Localized Cutaneous Malignant Melanoma
por: Sandru, Angela, et al.
Publicado: (2014)

CTIM-21. PEPTIDE VACCINE DIRECTED TO CMV pp65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL
por: Thompson, Eric, et al.
Publicado: (2020)

Cutaneous malignant melanoma in Northern Ireland.
por: Pedlow, P. J., et al.
Publicado: (1997)

MALIGNANT MELANOMA – CUTANEOUS METASTASES
por: Padmavathy, L, et al.
Publicado: (2008)

Cutaneous Horn Malignant Melanoma
por: Nishida, Haruto, et al.
Publicado: (2013)

Cutavirus in Cutaneous Malignant Melanoma
por: Mollerup, Sarah, et al.
Publicado: (2017)

EPCT-13. CMV PP65 RNA-PULSED DENDRITIC CELL VACCINES FOR PEDIATRIC GLIOBLASTOMA AND MEDULLOBLASTOMA: PHASE I TRIAL RESULTS
por: Landi, Daniel, et al.
Publicado: (2020)

Analysis of memory T lymphocyte activity following stimulation with overlapping HLA-A*2402, A*0101 and Cw*0402 restricted CMV pp65 peptides
por: Ghei, Monica, et al.
Publicado: (2005)

Human cytomegalovirus tegument proteins (pp65, pp71, pp150, pp28)
por: Tomtishen III, John Paul
Publicado: (2012)

Prognostic impact of p62 expression in cutaneous malignant melanoma
por: Ellis, Robert A, et al.
Publicado: (2013)

A Texture Based Pattern Recognition Approach to Distinguish Melanoma from Non-Melanoma Cells in Histopathological Tissue Microarray Sections
por: Rexhepaj, Elton, et al.
Publicado: (2013)

HSP105 expression in cutaneous malignant melanoma: Correlation with clinicopathological characteristics
por: Chen, Ke-Jun, et al.
Publicado: (2021)

EPCT-01. A NOVEL PEPTIDE VACCINE DIRECTED TO CMV PP65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL
por: Thompson, Eric, et al.
Publicado: (2021)

Problems with registration of cutaneous malignant melanoma in England.
por: Melia, J., et al.
Publicado: (1995)

Worldwide Increasing Incidences of Cutaneous Malignant Melanoma
por: Godar, Dianne E.
Publicado: (2011)

Primary cutaneous malignant melanoma of the breast
por: Kim, Seon Kwang, et al.
Publicado: (2012)

Primary Cilium Depletion Typifies Cutaneous Melanoma In Situ and Malignant Melanoma
por: Kim, Jinah, et al.
Publicado: (2011)

Comprehensive Analysis of CD4(+) T Cell Responses to CMV pp65 Antigen Restricted by Single HLA-DR, -DQ, and -DP Allotype Within an Individual
por: Hyun, You-Seok, et al.
Publicado: (2021)

Recombinant luciferase-expressing human cytomegalovirus (CMV) for evaluation of CMV inhibitors
por: He, Ran, et al.
Publicado: (2011)

SDHD promoter mutations are rare events in cutaneous melanomas but SDHD protein expression is downregulated in advanced cutaneous melanoma
por: Pópulo, Helena, et al.
Publicado: (2017)

Circulating miR-221 Expression Level and Prognosis of Cutaneous Malignant Melanoma
por: Li, Ping, et al.
Publicado: (2014)

Genetic determinants of cutaneous malignant melanoma in Sinclair swine.
por: Blangero, J., et al.
Publicado: (1996)

A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 antigenemia assay in monitoring patients after allogeneic stem cell transplantation
por: Gentile, Giuseppe, et al.
Publicado: (2006)

Sunburn, suntan and the risk of cutaneous malignant melanoma--The Western Canada Melanoma Study.
por: Elwood, J. M., et al.
Publicado: (1985)

A Fully Protective Congenital CMV Vaccine Requires Neutralizing Antibodies to Viral Pentamer and gB Glycoprotein Complexes but a pp65 T-Cell Response Is Not Necessary
por: Choi, K. Yeon, et al.
Publicado: (2021)

Cutaneous malignant melanoma “recurred as” or “in coexistence” with meningioma?
por: Rahmah, Nunung Nur, et al.
Publicado: (2010)

Diffuse Cutaneous Melanosis Associated with Malignant Melanoma
por: Mangana, Joanna, et al.
Publicado: (2015)

Established and Emerging Biomarkers in Cutaneous Malignant Melanoma
por: Verykiou, Stamatina, et al.
Publicado: (2014)

Clinical Characteristics of Cutaneous Melanoma and Second Primary Malignancies in a Dutch Hospital-Based Cohort of Cutaneous Melanoma Patients
por: van der Velden, Haike M. J., et al.
Publicado: (2009)

Metastatic breast disease from cutaneous malignant melanoma()
por: Moschetta, Marco, et al.
Publicado: (2013)

The incidence and pathogenesis of invasive cutaneous malignant melanoma in Northern Ireland.
por: Gordon, L. G., et al.
Publicado: (1986)

The Influence of Pregnancy on the Recurrence of Cutaneous Malignant Melanoma in Women
por: Albersen, M., et al.
Publicado: (2010)

Cutaneous malignant melanoma in two rabbits (Oryctolagus cuniculus)
por: UEDA, Kengo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_o7kli18ospl0vhsavb4rlea0rb